Edwards Lifesciences Corporation is the global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. Driven by a passion to help patients, we partner with the world’s leading clinicians and researchers and invest in research and development to transform care for those impacted by structural heart disease or who require hemodynamic monitoring during surgery or in intensive care. Edwards Lifesciences has a proud six-decade history as a leader in these areas. Since our founder, Lowell Edwards, first dreamed of using engineering to address diseases of the human heart, we have steadily built a company on the premise of imagining, building, and realizing a better future for patients.
A pioneer in the development of heart valve therapies, we are the world’s leading manufacturer of heart valve systems and repair products used to replace or repair a patient’s diseased or defective heart valve. Our innovative work in heart valves encompasses both surgical and transcatheter therapies for heart valve replacement and repair. We are also a global leader in hemodynamic monitoring systems used to measure a patient’s cardiovascular function in the hospital setting.
Fractal EDM stands on the research frontier of health economics, decision science and outcomes research. We can translate clinical consequences into outcomes that matter for the patients, the health system and society, bridging the gap towards policymaking.
The triple aim is at our core. We use our knowledge to move towards better care at a lower cost, suggesting that our clients implement risk-driven health interventions for populations, allocating resources to avoid consequences rather than treating them.
Our work units are:
More information www.fractaledm.com